October 2023

• All the links have been checked and are working properly.

• Plitidepsin: The compound has been removed as it currently has active Phase 3 clinical trial. Plitidepsin is moved to Phase 2 for an active clinical trial for Coronavirus.

​

August 2023

• All the links have been checked and were working properly.

​

June 2023

• The new UPDATE report was discussed and will be posted for June 2023.

• All the links have been checked and were working properly.

• Marizomib (Salinosporamide A; NPI-0052) is now in the Bristol Myers Squibb pipeline.

​

April 2023

• The new UPDATE report was discussed and will be posted for April 2023.

• The following clinical trial numbers have changed:

• Ladiratuzumab vedotin (SGN-LIV1A) a. “[5+]” to “[4+]” under US – Active Clinical Trials

​

February 2023

• All the links have been checked and were working properly. Recent changes in the number of active clinical trials in Phase 3 are shown below.

• Plitidepsin has a new US Active Phase 3 trial that is updated to the Phase 3 webpage.

• Upiftamab rilsodotin (XMT-1536) has a new US Active and European Active Phase 3 trial that is updated to the Phase 3 webpage.

​

December 2022

• All the links have been checked and were working properly. The number of clinical trials in Phase 3 is currently reflected on the website.  

​

September 2022

• During September copyright notices were posted on the top and bottom of this page.

• Plinabulin has 5 US Active Trials.

• XMT-1536 (upifitamab rilsodotin) has a new US Active Phase 3 trial has been added to the Phase 3 webpage.